Prevalence of andropause among Iranian men and its relationship with quality of life

References

• Konaka H, Sugimoto K, Orikasa H, et al. Effects of long-term androgen replacement therapy on the physical and mental statuses of aging males with late-onset hypogonadism: a multicenter, randomized controlled trial in Japan (EARTH Study). Asian J Androl. 2016;18:25–34.
   PubMed Web of Science ®Google Scholar
• Tan RS, Cook KR, Reilly WG. High estrogen in men after injectable testosterone therapy: the low T experience. Am J Mens Health. 2015;9:229–234.
   PubMed Web of Science ®Google Scholar
• Shigehara K, Konaka H, Koh E, et al. Effects of testosterone replacement therapy on nocturia and quality of life in men with hypogonadism: a subanalysis of a previous prospective randomized controlled study in Japan. Aging Male. 2015;18:169–174.
   PubMed Web of Science ®Google Scholar
• Satkunasivam R, Ordon M, Hu B, et al. Hormone abnormalities are not related to the erectile dysfunction and decreased libido found in many men with infertility. Fertil Steril. 2014;101:1594–1598.
   PubMed Web of Science ®Google Scholar
• Stas SN, Anastasiadis AG, Fisch H, et al. Urologic aspects of andropause. Urology. 2003;61:261–266.
   PubMed Web of Science ®Google Scholar
• Groti K, Žuran I, Antonič B, et al. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes. Aging Male. 2018;1–12. DOI:10.1080/13685538.2018.1468429
   Web of Science ®Google Scholar
• Afsharnia E, Pakgohar M, Khosravi S, et al. Examining the effect of the computer-based educational package on quality of life and severity of hypogonadism symptoms in males. Aging Male. 2018;21:85–92.
   PubMed Web of Science ®Google Scholar
• Haren MT, Kim MJ, Tariq SH, et al. Andropause: a quality-of-life issue in older males. Med Clin North Am. 2006;90:1005–1023.
   PubMed Web of Science ®Google Scholar
• Staerman F, Leon P. Andropause (androgen deficiency of the aging male): diagnosis and management. Minerva Med. 2012;103:333–342.
   PubMed Web of Science ®Google Scholar
• Schwarz ER, Phan A, Willix RD Jr. Andropause and the development of cardiovascular disease presentation – more than an epi-phenomenon. J Geriatr Cardiol. 2011;8:35–43.
   PubMedGoogle Scholar
• Khosravi S, Ardebili HE, Larijani B, et al. Are andropause symptoms related to depression? Aging Clin Exp Res. 2015;27:813–820.
   PubMed Web of Science ®Google Scholar
• Samipoor F, Pakseresht S, Rezasoltani P, et al. The association between hypogonadism symptoms with serum testosterone, FSH and LH in men. Aging Male. 2018;21:1–8.
   PubMed Web of Science ®Google Scholar
• Panach-Navarrete J, Martinez-Jabaloyas JM. The influence of comorbidities on the aging males' symptoms scale in patients with erectile dysfunction. Aging Male. 2017;20:146–152.
   PubMed Web of Science ®Google Scholar
• Abootalebi M, Kargar M, Aminsharifi A. Assessment of the validity and reliability of a questionnaire on knowledge and attitude of general practitioners about andropause. Aging Male. 2017;20:60–64.
   PubMed Web of Science ®Google Scholar
• Renneboog B. Andropause and testosterone deficiency: how to treat in 2012?. Rev Med Brux. 2012;33:443–449.
   PubMedGoogle Scholar
• Chen RY, Ng KK. Self-referred older Asian males in a men's health clinic: the inter-relationships between androgens, metabolic parameters and quality of life measures. Aging Male. 2010;13:233–241.
   PubMed Web of Science ®Google Scholar
• Jankowska EA, Szklarska A, Lopuszanska M, et al. Age and social gradients in the intensity of aging males' symptoms in Poland. Aging Male. 2008;11:83–88.
   PubMed Web of Science ®Google Scholar
• Delev DP, Kostadinova II, Kostadinov ID, et al. Physiological and clinical characteristics of andropause. Folia Med (Plovdiv). 2009;51:15–22.
   PubMedGoogle Scholar
• Afsharnia E, Pakgohar M, Khosravi S, et al. The quality of life and related factors in men with andropause. Hayat, J School Nursing Midwifery, Tehran Univ Med Sci. 2016;22:38–49. (Persian).
   Google Scholar
• Al-Sejari M. Prevalence of andropausal symptoms among Kuwaiti males. Am J Mens Health. 2013;7:516–522.
   PubMed Web of Science ®Google Scholar
• Samipoor F, Pakseresht S, Rezasoltani P, et al. Awareness and experience of andropause symptoms in men referring to health centers: a cross-sectional study in Iran. Aging Male. 2017;20:153–160.
   PubMed Web of Science ®Google Scholar
• Singh P. Andropause: current concepts. Indian J Endocrinol Metab. 2013;17:S621–S629.
   PubMedGoogle Scholar
• Kaya E, Sikka SC, Kadowitz PJ, et al. Aging and sexual health: getting to the problem. Aging Male. 2017;20:65–80.
   PubMed Web of Science ®Google Scholar
• Mimoun S. Ménopause, andropause et fonction sexuelle; Menopause, andropause and sexuality. Gynecol Obstet Fert. 2003;31:141–146.
   PubMedGoogle Scholar
• Jannini EA, Nappi RE. Couplepause: a new paradigm in treating sexual dysfunction during menopause and andropause. Sex Med Rev. 2018;6:384–395.
   PubMed Web of Science ®Google Scholar
• Kratzik CW, Reiter WJ, Riedl AM, et al. Hormone profiles, body mass index and aging male symptoms: results of the Androx Vienna Municipality study. Aging Male. 2004;7:188–196.
   PubMedGoogle Scholar
• Baas W, Kohler TS. Testosterone replacement therapy and voiding dysfunction. Transl Androl Urol. 2016;5:890–897.
   PubMed Web of Science ®Google Scholar
• Charandabi SM, Rezaei N, Hakimi S, et al. Sleep disturbances and sexual function among men aged 45–75 years in an urban area of Iran. Sleep Sci. 2016;9:29–34.
   PubMed Web of Science ®Google Scholar
• Shigehara K, Namiki M. Late-onset hypogonadism syndrome and lower urinary tract symptoms. Korean J Urol. 2011;52:657–663.
   PubMedGoogle Scholar
• Basu AK, Singhania P, Bandyopadhyay R, et al. Late onset hypogonadism in type 2 diabetic and nondiabetic male: a comparative study. J Indian Med Assoc. 2012;110:573–575.
   PubMedGoogle Scholar
• Shigehara K, Konaka H, Sugimoto K, et al. Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea. Aging Male. 2018;21:99–105.
   PubMed Web of Science ®Google Scholar
• Ehsanpour S, Eivazi M, Davazdah-Emami S. Quality of life after the menopause and its relation with marital status. IJNMR 2007;12:130–135.
   Google Scholar
• Montazeri A, Vahdaninia M, Mousavi SJ, et al. The Iranian version of 12-item Short Form Health Survey (SF-12): factor structure, internal consistency and construct validity. BMC Public Health. 2009;9:341.
   PubMed Web of Science ®Google Scholar
• Mohammadalizadeh Charandabi S, Rezaei N, Hakimi S, et al. Quality of life of postmenopausal women and their spouses: a community-based study. Iran Red Crescent Med J. 2015;17:e21599.
   PubMed Web of Science ®Google Scholar
• Heiman JR, Long JS, Smith SN, et al. Sexual satisfaction and relationship happiness in midlife and older couples in five countries. Arch Sex Behav. 2011;40:741–753.
   PubMed Web of Science ®Google Scholar
• Farahat TM, Maraee AH, Hegazy NN, et al. Quality of life in patients with erectile dysfunction in Shebin El Kom District. Menoufia Med J. 2017;30:607–613.
   Google Scholar
• Gökçe Mİ, Yaman Ö. Erectile dysfunction in the elderly male. Turk J Urol. 2017;43:247–251.
   PubMed Web of Science ®Google Scholar
• Cayan S, Kendirci M, Yaman O, et al. Prevalence of erectile dysfunction in men over 40 years of age in Turkey: results from the Turkish Society of Andrology Male Sexual Health Study Group. Turk J Urol. 2017;43:122–129.
   PubMed Web of Science ®Google Scholar
• Gareri P, Castagna A, Francomano D, et al. Erectile dysfunction in the elderly: an old widespread issue with novel treatment perspectives. Int J Endocrinol. 2014;2014:878670.
   PubMed Web of Science ®Google Scholar
• Statistical Center of Iran, The President’s Office Deputy of Strategic Planning and Control. National population and housing Census 2011 (1390): Selected Findings. Tehran: The Center; October 24, 2011.
   Google Scholar
• Asadollahi A, Saberi LF, Faraji N. Validity and reliability of male andropause symptoms self-assessment questionnaire among elderly males in Khuzestan province of Iran. J Mid-Life Health. 2013;4:233–237.
   PubMedGoogle Scholar
• Park NC, Yan BQ, Chung JM, et al. Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency. Aging Male. 2003;6:86–93.
   PubMedGoogle Scholar
• Reddy P, White CM, Dunn AB, et al. The effect of testosterone on health-related quality of life in elderly males – a pilot study. J Clin Pharm Ther. 2000;25:421–426.
   PubMed Web of Science ®Google Scholar
• Adebajo S, Odeyemi K, Oyediran M, et al. Knowledge and experiences of andropause among men in Lagos, Nigeria. West Afr J Med. 2007;26:106–112.
   PubMedGoogle Scholar
• Novak A, Brod M, Elbers J. Andropause and quality of life: findings from patient focus groups and clinical experts. Maturitas. 2002;43:231–237.
   PubMed Web of Science ®Google Scholar
• Kulej-Lyko K, Majda J, von Haehling S, et al. Could gonadal and adrenal androgen deficiencies contribute to the depressive symptoms in men with systolic heart failure? Aging Male. 2016;19:221–230.
   PubMed Web of Science ®Google Scholar
• Nisar N, Ahmed-Sohoo N. Severity of menopausal symptoms and the quality of life at different status of menopause: a community base survey from rural Sindh, Pakistan. IJCRIMPH. 2010;2:118–130.
   Google Scholar
• Tan RS, Culberson JW. An integrative review on current evidence of testosterone replacement therapy for the andropause. Maturitas. 2003;45:15–27.
   PubMed Web of Science ®Google Scholar
• Salman M, Yassin D-J, Shoukfeh H, et al. Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy. Aging Male. 2017;20:45–48.
   PubMed Web of Science ®Google Scholar
• Frederiksen L, Højlund K, Hougaard DM, et al. Testosterone therapy increased muscle mass and lipid oxidation in aging men. Age (Dordr). 2012;34:145–156.
   PubMed Web of Science ®Google Scholar
• Magnussen LV, Glintborg D, Hermann P, et al. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy. Diabetes Obes Metab. 2016;18:980–989.
   PubMed Web of Science ®Google Scholar
• Shigehara K, Konaka H, Koh E, et al. Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study). Aging Male. 2017;20:139–145.
   PubMed Web of Science ®Google Scholar
• Abootalebi M, Kargar M, Jahanbin I, et al. Knowledge and attitude about andropause among general physicians in Shiraz, Iran 2014. Int J Community Based Nurs Midwifery. 2016;4:27–35.
   PubMedGoogle Scholar